Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 263

Results For "LTI"

2943 News Found

WHO grants EUL for Covovax
Drug Approval | December 20, 2021

WHO grants EUL for Covovax

First Emergency Use Listing granted by WHO for a protein-based Covid-19 vaccine


ICMR invites EOI for Omicron detection kits
News | December 20, 2021

ICMR invites EOI for Omicron detection kits

The Indian Council of Medical Research (ICMR), intends to enter into non-exclusive agreements with companies


Moderna says Covid-19 booster dose works against Omicron in lab study
News | December 20, 2021

Moderna says Covid-19 booster dose works against Omicron in lab study

Authorized booster increases Omicron neutralizing antibody levels approximately 37-fold


Novel Concepts Medical’s formula disrupts Covid-19 spike protein
Biotech | December 17, 2021

Novel Concepts Medical’s formula disrupts Covid-19 spike protein

The company is now ready to offer clinical testing anywhere in the world after early case studies conducted in Israel have demonstrated recovery within 48 hours


Boyd Corporation acquires MBK Tape Solutions
Packaging | December 17, 2021

Boyd Corporation acquires MBK Tape Solutions

Medical footprint expansion with deeper medical grade skin contact material science expertise


New data suggests Covaxin generates robust memory to Covid-19 and variants six months after vaccination
Biotech | December 17, 2021

New data suggests Covaxin generates robust memory to Covid-19 and variants six months after vaccination

Effectiveness of Covaxin against the Omicron variant is currently being studied


Syngene extends contract with Amgen till 2026
News | December 16, 2021

Syngene extends contract with Amgen till 2026

Syngene will also build and operate a new dedicated drug development laboratory to accelerate the advancement of Amgen R&D projects


Immatics and Bristol Myers Squibb enter exclusive license for TCR Bispecific programme
Biotech | December 15, 2021

Immatics and Bristol Myers Squibb enter exclusive license for TCR Bispecific programme

Immatics to receive upfront payment of US $ 150 million and additional milestone payments of up to US $ 770 million plus tiered double-digit royalties on net product sales


Biogen and TheraPanacea collaborate to advance digital health in neuroscience
Biotech | December 15, 2021

Biogen and TheraPanacea collaborate to advance digital health in neuroscience

Collaboration aims to develop innovative machine learning and artificial intelligence solutions for personalized and earlier treatment in neurology